Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Catalyst Bio (CBIO)

Catalyst Bio (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,418
  • Shares Outstanding, K 37,978
  • Annual Sales, $ 790 K
  • Annual Income, $ -8,240 K
  • 60-Month Beta 1.05
  • Price/Sales 25.12
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CBIO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.50
  • Most Recent Earnings $-0.04 on 10/26/23
  • Latest Earnings Date 11/13/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend 0.569 on 08/20/15
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.04
  • Number of Estimates 1
  • High Estimate -0.04
  • Low Estimate -0.04
  • Prior Year -1.28
  • Growth Rate Est. (year over year) +96.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3200 +59.78%
on 10/13/23
0.5880 -13.04%
on 10/20/23
+0.0290 (+6.01%)
since 09/29/23
3-Month
0.3200 +59.78%
on 10/13/23
0.7400 -30.91%
on 08/23/23
+0.1364 (+36.38%)
since 07/28/23
52-Week
0.1887 +170.96%
on 03/20/23
0.7400 -30.91%
on 08/23/23
-0.0695 (-11.97%)
since 10/28/22

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHBI, CBIO, TA, ASRT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SHBI : 10.35 (+1.87%)
CBIO : 7.6695 (-2.65%)
TA : 86.00 (-0.01%)
ASRT : 0.7800 (+3.45%)
SHAREHOLDER ALERT: Weiss Law Reminds MLVF, SHBI, CBIO, and TA Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

MLVF : 16.97 (+0.24%)
SHBI : 10.35 (+1.87%)
CBIO : 7.6695 (-2.65%)
TA : 86.00 (-0.01%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TA, CBIO, AQUA

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TA : 86.00 (-0.01%)
CBIO : 7.6695 (-2.65%)
AQUA : 49.88 (+0.95%)
SHAREHOLDER ALERT: Weiss Law Reminds CBIO, TA, AQUA, and USX Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

CBIO : 7.6695 (-2.65%)
TA : 86.00 (-0.01%)
AQUA : 49.88 (+0.95%)
USX : 6.14 (unch)
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates TA, GMED, CBIO, AQUA

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TA : 86.00 (-0.01%)
GMED : 50.72 (-0.06%)
CBIO : 7.6695 (-2.65%)
AQUA : 49.88 (+0.95%)
SHAREHOLDER ALERT: Weiss Law Reminds CBIO, TA, AQUA, and USX Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

CBIO : 7.6695 (-2.65%)
TA : 86.00 (-0.01%)
AQUA : 49.88 (+0.95%)
USX : 6.14 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHBI, CBIO, AQUA, LBC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SHBI : 10.35 (+1.87%)
CBIO : 7.6695 (-2.65%)
AQUA : 49.88 (+0.95%)
LBC : 9.15 (+0.55%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CBIO, ANGN, AQUA, OSH

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CBIO : 7.6695 (-2.65%)
ANGN : 10.0000 (+2.04%)
AQUA : 49.88 (+0.95%)
OSH : 39.00 (+0.08%)
SHAREHOLDER ALERT: Weiss Law Reminds SHBI, CBIO, TA, and AQUA Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

SHBI : 10.35 (+1.87%)
CBIO : 7.6695 (-2.65%)
TA : 86.00 (-0.01%)
AQUA : 49.88 (+0.95%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PTRS, CBIO, AQUA, OSH

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PTRS : 7.15 (+0.99%)
CBIO : 7.6695 (-2.65%)
AQUA : 49.88 (+0.95%)
OSH : 39.00 (+0.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Catalyst Biosciences, Inc. is a biopharmaceutical company which focused on creating and developing medicines to address serious medical conditions. The Company's hemostasis product candidates include CB 813d/PF-0520602, CB 2679d/ISU 304 and FXa. Anti-Complement Product consists of CB 2782 and Ophthalmic...

See More

Key Turning Points

3rd Resistance Point 0.6669
2nd Resistance Point 0.6232
1st Resistance Point 0.5673
Last Price 7.6695
1st Support Level 0.4677
2nd Support Level 0.4240
3rd Support Level 0.3681

See More

Last Price 7.6695
52-Week High 0.7400
Fibonacci 61.8% 0.5294
Fibonacci 50% 0.4644
Fibonacci 38.2% 0.3993
52-Week Low 0.1887

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar